Treatment of TNFalpha related disorders

Methods of treating TNFalpha-related disorders comprising administering TNFalpha inhibitors, including TNFalpha antibodies are described.

Saved in:
Bibliographic Details
Main Authors TAYLOR LORI K, CHARTASH ELLIOT K, HOFFMAN REBECCA S, YAN PHILIP, MURTAZA ANWAR, FISCHKOFF STEVEN, SPIEGLER CLIVE E, SALFELD JOCHEN G, BANERJEE SUBHASHIS, BARCHUK WILLIAM T, TRACEY DANIEL EDWARD
Format Patent
LanguageEnglish
Published 01.07.2004
Edition7
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract Methods of treating TNFalpha-related disorders comprising administering TNFalpha inhibitors, including TNFalpha antibodies are described.
AbstractList Methods of treating TNFalpha-related disorders comprising administering TNFalpha inhibitors, including TNFalpha antibodies are described.
Author BARCHUK WILLIAM T
YAN PHILIP
HOFFMAN REBECCA S
SALFELD JOCHEN G
FISCHKOFF STEVEN
CHARTASH ELLIOT K
MURTAZA ANWAR
TAYLOR LORI K
BANERJEE SUBHASHIS
SPIEGLER CLIVE E
TRACEY DANIEL EDWARD
Author_xml – fullname: TAYLOR LORI K
– fullname: CHARTASH ELLIOT K
– fullname: HOFFMAN REBECCA S
– fullname: YAN PHILIP
– fullname: MURTAZA ANWAR
– fullname: FISCHKOFF STEVEN
– fullname: SPIEGLER CLIVE E
– fullname: SALFELD JOCHEN G
– fullname: BANERJEE SUBHASHIS
– fullname: BARCHUK WILLIAM T
– fullname: TRACEY DANIEL EDWARD
BookMark eNrjYmDJy89L5WRQDylKTSzJTc0rUchPUwjxc0vMKchIVChKzUksSU1RSMkszi9KSS0q5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgYGJoZGZsbmRo6GxsSpAgASuypd
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 7
ExternalDocumentID US2004126372A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2004126372A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:54:51 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2004126372A13
Notes Application Number: US20030622932
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040701&DB=EPODOC&CC=US&NR=2004126372A1
ParticipantIDs epo_espacenet_US2004126372A1
PublicationCentury 2000
PublicationDate 20040701
PublicationDateYYYYMMDD 2004-07-01
PublicationDate_xml – month: 07
  year: 2004
  text: 20040701
  day: 01
PublicationDecade 2000
PublicationYear 2004
RelatedCompanies ABBOTT BIOTECHNOLOGY LTD
RelatedCompanies_xml – name: ABBOTT BIOTECHNOLOGY LTD
Score 2.6025212
Snippet Methods of treating TNFalpha-related disorders comprising administering TNFalpha inhibitors, including TNFalpha antibodies are described.
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Treatment of TNFalpha related disorders
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040701&DB=EPODOC&locale=&CC=US&NR=2004126372A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsTRONTEzA8YAsPVtomuSlGyum5hskqybaGFpCGwdGKckm4I2J_v6mXmEmnhFmEYwMeTA9sKAzwktBx-OCMxRycD8XgIurwsQg1gu4LWVxfpJmUChfHu3EFsXNVjvGNg9AfaNXZxsXQP8Xfyd1ZydbUOD1fyCwHKGRmbG5kaOwL4SK6ghDTpp3zXMCbQvpQC5UnETZGALAJqXVyLEwJSaJ8zA6Qy7e02YgcMXOuUNZEJzX7EIg3oIbFW4Qn6aQoifG3ijrAJ4O0pqikIK9CDNYlEGZTfXEGcPXaCN8XAPxocGIzvPWIyBBdj1T5VgUACGlEFaqqGRebKZObClk2QJ7E8YpBompxpZmBmnGVpIMsjgM0kKv7Q0AxdkHQpo8akMA0tJUWmqLLCKLUmSA4cMAEr1fZQ
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq-KjakCJp2Dz6CY5BLGbhqhNWmwivYVmswFB2mIi_n0na6I99bbswD6Znfl255sFuLV1bhCCO4Det6EYKTOVBTOYsrBsFb0DPWODipwchMSPjef5YN6Cj4YLI_KEfovkiKhRDPW9FOf1-v8SyxWxlcV9-o5Vqwcvcly5QccITxAbu0NnNJ24EypT6sQzOXwVMlUjuqk9IlbaMREUCrD0Nqx4KetNo-IdwO4U21uWh9Diyy50aPP3Whf2gvrJG4u19hVHcBc1UeHSKpei0BNEWUnQUXgmZXUizeIYbrxRRH0Fe0z-JpjEs83h6SfQRujPT0HClernXNVMRkz0dFIb8USfq4xrFtFz1TqD3raWzreLr6HjR8E4GT-FLxew_xuTUgWi9qBdfn7xSzS3ZXolVukHTzOAfg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Treatment+of+TNFalpha+related+disorders&rft.inventor=TAYLOR+LORI+K&rft.inventor=CHARTASH+ELLIOT+K&rft.inventor=HOFFMAN+REBECCA+S&rft.inventor=YAN+PHILIP&rft.inventor=MURTAZA+ANWAR&rft.inventor=FISCHKOFF+STEVEN&rft.inventor=SPIEGLER+CLIVE+E&rft.inventor=SALFELD+JOCHEN+G&rft.inventor=BANERJEE+SUBHASHIS&rft.inventor=BARCHUK+WILLIAM+T&rft.inventor=TRACEY+DANIEL+EDWARD&rft.date=2004-07-01&rft.externalDBID=A1&rft.externalDocID=US2004126372A1